(1)
BUSINESS RISK, DIVIDEND POLICY, CAPITAL STRUCTURE ON FINANCIAL PERFORMANCE: A STUDY IN INDONESIAN PHARMACEUTICAL COMPANIES. IJEIRC 2024, 1 (10), 41-63. https://doi.org/10.61796/ijeirc.v1i10.275.